The Safety and Efficacy of Multiple-dose of JS002 in Subject With Hyperlipidemia

NCT04781114 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

806

Enrollment

OTHER

Sponsor class

Conditions

Hyperlipemia

Interventions

DRUG: JS002
DRUG: Placebo

Sponsor

Shanghai Junshi Bioscience Co., Ltd.